Thomas W. Schoenfeld
Keine laufenden Positionen mehr
Profil
Thomas W.
Schoenfeld was the founder who co-founded Lucigen Corp.
in 1998 and held the title of Vice President-Translational Research.
He has a graduate degree from Marquette University and an undergraduate degree from Carroll University, Inc.
Ehemalige bekannte Positionen von Thomas W. Schoenfeld
| Unternehmen | Position | Ende |
|---|---|---|
Lucigen Corp.
 Lucigen Corp. Pharmaceuticals: MajorHealth Technology Lucigen Corp. engages in the development, manufacture, and sale of biomedical research products and services. The firm offers products for array-based analysis; cloning kits and vectors; competent cells; enzymes; in vitro transcription; next gen sequencing (NGS); nucleic acid extraction and purification; PCR and amplification; protein expression; and transposon mutagenesis. It also provides NGS and custom competent cell services. The company was founded by David Mead and Thomas W. Schoenfeld in 1998 and is headquartered in Middleton, WI. | Gründer | - |
Ausbildung von Thomas W. Schoenfeld
| Carroll University, Inc. | Undergraduate Degree |
| Marquette University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Lucigen Corp.
Lucigen Corp. Pharmaceuticals: MajorHealth Technology Lucigen Corp. engages in the development, manufacture, and sale of biomedical research products and services. The firm offers products for array-based analysis; cloning kits and vectors; competent cells; enzymes; in vitro transcription; next gen sequencing (NGS); nucleic acid extraction and purification; PCR and amplification; protein expression; and transposon mutagenesis. It also provides NGS and custom competent cell services. The company was founded by David Mead and Thomas W. Schoenfeld in 1998 and is headquartered in Middleton, WI. | Health Technology |
